WHO ICTRP trial

A study on the mechanism of neuroinflammation involved in the treatment…

ChiCTR2400086345 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2400086345
Public title A study on the mechanism of neuroinflammation involved in the treatment resistance to SSRIs/SNRIs in patients with major depressive disorder and a history of childhood trauma
Scientific title A study on the mechanism of neuroinflammation involved in the treatment resistance to SSRIs/SNRIs in patients with major depressive disorder and a history of childhood trauma
Primary sponsor The Second Xiangya Hospital of Central South University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 4
Countries China
Conditions Major Depressive Disorder;F32.900
Interventions Experimental group:The minocycline group is treated with minocycline hydrochloride capsules for 8 weeks on the basis of original SSRIs or SNRIs treatment, with a treatment dose of 100mg/bid.;Control group:The control group still maintains…
Registration date Jun 28, 2024
Target size Experimental group:20;Control group:20
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations